144 employees
Touchlight Genetics develops a DNA production platform designed for the development of DNA vaccines for oncology and infectious diseases.
2008
$2.4M
from 2 investors over 2 rounds
Touchlight raised $2.4M on November 28, 2022
Investors: Bill & Melinda Gates Foundation
Touchlight raised undisclosed on December 12, 2017
Investors: Innovate UK